From Lab to Scale in India: What Biotech startups must get right before approaching CDMOs

For many biotech startups, the real risk does not lie in the science — it emerges when promising lab results meet the realities of scale-up, tech transfer, manufacturing, and regulatory execution. This webinar is designed for founders and early teams across biotechnology domains (synthetic biology, agri-biotech, med-tech, industrial biotech, nutraceuticals, and adjacent areas) who are preparing to move beyond proof-of-concept and engage with CROs, CDMOs, or manufacturing partners.